Cargando…
Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry
Background: Portopulmonary hypertension (PoPH) is one of the major underlying causes of pulmonary arterial hypertension (PAH). However, PoPH, especially treatment strategies, has been poorly studied. Therefore, this study evaluated current treatments for PoPH, their efficacy, and clinical outcomes o...
Autores principales: | Tamura, Yudai, Tamura, Yuichi, Taniguchi, Yu, Tsujino, Ichizo, Inami, Takumi, Matsubara, Hiromi, Shigeta, Ayako, Sugiyama, Yoichi, Adachi, Shiro, Abe, Kohtaro, Baba, Yuichi, Hatano, Masaru, Ikeda, Satoshi, Kusunose, Kenya, Sugimura, Koichiro, Usui, Soichiro, Takeishi, Yasuchika, Dohi, Kaoru, Hasegawa-Tamba, Saki, Horimoto, Koshin, Kikuchi, Noriko, Kumamaru, Hiraku, Tatsumi, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638513/ https://www.ncbi.nlm.nih.gov/pubmed/36408361 http://dx.doi.org/10.1253/circrep.CR-22-0098 |
Ejemplares similares
-
Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023) -
Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan
por: Tamura, Yuichi, et al.
Publicado: (2022) -
Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021) -
SATISFY‐JP, a phase II multicenter open‐label study on Satralizumab, an anti‐IL‐6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune‐responsive‐phenotype: Study protocol
por: Tamura, Yuichi, et al.
Publicado: (2023) -
Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension ― Multicenter Study in Japan ―
por: Takeyasu, Rika, et al.
Publicado: (2020)